NovaBridge Biosciences (NBP) Other Accumulated Expenses (2019 - 2026)
NovaBridge Biosciences (NBP) recorded Other Accumulated Expenses of $8.88 million in Q2 2026, up 940.8% from $853,000 a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, NovaBridge Biosciences reported Other Accumulated Expenses of $9.18 million.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 49.4% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $106,000 in FY2024, -$3.09 million in FY2023, $3.47 million in FY2022 (-27.8%) and $4.81 million in FY2021 (+289.7%).
- Quarterly Other Accumulated Expenses has ranged from $106,000 in Q4 2024 to $9.18 million in Q4 2025 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses rose in three of the last four quarters, with growth averaging 219.0%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 940.8% in Q2 2026, against a decline of 96.5% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | NovaBridge Biosciences | 149.78 Mn | 149.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.88 Mn |
| Dec 31, 2025 | 9.18 Mn |
| Sep 30, 2025 | 872,000.00 |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 835,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 753,000.00 |
| Jun 30, 2024 | 737,000.00 |
| Dec 31, 2023 | 3.04 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Jun 30, 2021 | 1.53 Mn |
| Dec 31, 2020 | 1.22 Mn |
| Sep 30, 2020 | 1.18 Mn |
| Jun 30, 2020 | 1.16 Mn |
| Dec 31, 2019 | 965,782.40 |
API Access
NovaBridge Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();